← Back to Search

Other

ALTENS for Swallowing Difficulty

Phase 1 & 2
Waitlist Available
Led By Raimond Wong, MD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after treatment completion
Awards & highlights

Study Summary

Study hypothesis: ALTENS techniques, administered within the first 3 months after radiation completion, can improve radiation-induced dysphagia and associated symptoms in head and neck cancer patients. This beneficial effect is mediated by the reduction of chronic inflammatory response of swallowing musculature to radiation, consequently a reduction in muscle fibrosis. Primary study objective: To evaluate the effectiveness of ALTENS in relieving radiation-induced dysphagia. Eating Assessment Tool (EAT-10) scores will be used for this primary study endpoint.

Eligible Conditions
  • Swallowing Difficulty
  • Head and Neck Cancers

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after treatment completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after treatment completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Subjective Dysphagia Assessment Score: EAT-10 from baseline
Secondary outcome measures
Change in M. D. Anderson dysphagia inventory from baseline

Trial Design

1Treatment groups
Experimental Treatment
Group I: ALTENSExperimental Treatment1 Intervention
Patients in this arm will be treated with Acupuncture-like Transcutaneous Electrical Nerve Stimulation using Codetron (Codetron ALTENS)

Find a Location

Who is running the clinical trial?

Hamilton Health Sciences CorporationOTHER
368 Previous Clinical Trials
300,966 Total Patients Enrolled
McMaster UniversityLead Sponsor
881 Previous Clinical Trials
2,597,851 Total Patients Enrolled
Raimond Wong, MDPrincipal InvestigatorMcMaster University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers
Raimond Wong 2012. "A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01697891.
All > Dysphagia
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top